|
Age group (yrs)
| |
|
19–30
|
7
|
|
31–40
|
3
|
|
41–50
|
4
|
|
51–60
|
0
|
|
> 60
|
5
|
|
Height (cm)
|
|
< 115
|
5
|
|
115–130
|
10
|
|
> 130
|
4
|
|
Reproductive health
|
|
Menarche (median, yrs)
|
12.5
|
|
Cycle length (variation, median, days)
|
21–60, 28
|
|
Menstrual flow
|
|
sparse
|
2
|
|
normal
|
15
|
|
heavy
|
2
|
|
Pregnancies
|
6/19
|
|
Births
|
|
0
|
14
|
|
1–2
|
1
|
|
> 2
|
4
|
|
Current hormonal therapy
|
5/19
|
|
Combined contraception pills
|
1
|
|
Progestin only -pills
|
2
|
|
Hormone replacement therapy
|
2
|
|
Immunodeficiency
|
|
Suseptibility to infectionsa
|
|
Yes
|
9
|
|
Intermediate
|
4
|
|
Normal
|
6
|
|
Previous skin warts
|
|
Yes
|
4
|
|
No
|
14
|
|
Repeated genital infections
|
6/19
|
|
Previous malignancyb
|
3
|
|
Leucocytes (× 109/L) (range, median)
|
3.2–13.4; 5.6
|
|
Lymphocytes (× 109/L) (range, median)
|
0.5–2.58; 1.22
|
|
Neutrophiles (× 109/L) (range, median)
|
1.74–10.65; 3.37
|
